Published in Gene Therapy Weekly, March 16th, 1998
It adds to a growing library of genes known to make some people more susceptible to the disease that causes dementia and eventual death. The gene controls production of bleomycin hydrolase (BH), enzyme and there are two versions of it in people - an "A" form and a "G" form.
Geneticist Robert Ferrell and colleagues at the University of Pittsburgh, Pennsylvania, compared 357 patients with sporadic Alzheimer's - meaning they have no strong family history of the brain-destroying illness - with 320 people who did not have...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.